1. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women;Abeliovich;Am. J. Hum. Genet.,1997
2. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer;Walsh;JAMA, J. Am. Med. Assoc.,2006
3. Association of BRCA1 with Rad51 in mitotic and meiotic cells;Scully;Cell,1997
4. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner;Chen;Cancer Res.,1996
5. Future possibilities in the prevention of breast cancer: intervention strategies in BRCA1 and BRCA2 mutation carriers;Eeles;Breast Cancer Res.,2000